Caroline Emilie B Thomsen
9PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 27, 2026
Bevacizumab and Tocotrienol in Recurrent Platinum-Resistant Ovarian Cancer, and the Role of HOXA9 as a Prognostic Biomarker.Elisabeth Emanuel Graae, Louise Faaborg, Rikke Fredslund Andersen
|Aug 30, 2023
Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study.Louise Raunkilde, Torben Frøstrup Hansen, Birgitte Mayland Havelund
|Sep 23, 2022
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer.Louise Raunkilde, Torben Frøstrup Hansen, Rikke Fredslund Andersen
|Mar 18, 2022
Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility.Caroline Brenner Thomsen, Amanda Dandanell Juul, Anna Cecilie Lefèvre
|Oct 23, 2021
The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer.Kristian Blomberg, Torben F Hansen, Claus L Brasen
|Aug 27, 2021
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer.Sara W C Wen, Rikke F Andersen, Kristian Rasmussen
Pageof 2
Frequent Collaborators
4 joint publications
Torben Frøstrup Hansen
4 joint publications
Lars Henrik Jensen
4 joint publications
Rikke Fredslund Andersen
2 joint publications
Louise Raunkilde
1 joint publications
Claus L Brasen
1 joint publications
Sara W C Wen
1 joint publications
Anders Jakobsen
1 joint publications
Birgitte Mayland Havelund
1 joint publications
Søren Rafael Rafaelsen
1 joint publications
Jan Lindebjerg
